Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T05:33:32.934Z Has data issue: false hasContentIssue false

Effectiveness of Containment Measures to Control the Spread of COVID-19 in North Africa

Published online by Cambridge University Press:  03 September 2020

Ouail Ouchetto*
Affiliation:
LIMSAD-FSAC, Hassan II University of Casablanca, Casablanca, Morocco FSJES-AC, Hassan II University of Casablanca, Casablanca, Morocco
Asmaa Drissi Bourhanbour
Affiliation:
Laboratory of Immunology, Ibn Rochd University Hospital Center, Casablanca, Morocco Laboratory of Clinical Immunology and Immuno-Allergy, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco
Mounir Boumhamdi
Affiliation:
FSJES-AC, Hassan II University of Casablanca, Casablanca, Morocco
*
Correspondence and reprint requests to Ouail Ouchetto, FSJES-AC, Km 8 Route d’El Jadida, B.P 5366 Maarif 20100, Casablanca20000, Morocco (e-mail: [email protected]).
Rights & Permissions [Opens in a new window]

Abstract

Objectives:

Since the first case of severe acute respiratory syndrome coronavirus-2, identified in December 2019, in Wuhan in China, the number of cases rapidly increased into a pandemic. Governments worldwide have adopted different strategies and measures to interrupt the transmission of coronavirus disease 2019 (COVID-19). The main objective was to report and evaluate the effectiveness of the adopted measures in North Africa countries.

Methods:

In these countries, the effective reproductive number R(t), the naïve case fatality rate, and the adjusted case fatality rate were estimated and compared on different dates.

Results:

The obtained results show that the early strict application of containment measures and confinement could help contain the spread of the epidemic and maintain the number of deaths low.

Conclusions:

These measures might be useful for other countries that are experiencing the start of local COVID-19 outbreaks. They could also serve to halt the spread of new epidemics or pandemics.

Type
Original Research
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2020 Society for Disaster Medicine and Public Health, Inc.

The World Health Organization (WHO) on March 11, 2020, declared the coronavirus disease 2019 (COVID-19) an outbreak a global pandemic. Indeed, since the first cases were reported in December 2019, in Wuhan in China,Reference Zhu, Zhang and Wang1 210 countries and territories around the world have declared more than 4,500,000 confirmed cases and 300,000 deaths on 13 May, 2020. In a very short time, health-care systems and society have been severely challenged by this emerging virus. COVID-19 is an infectious disease caused by a newly discovered coronavirus. This pathogen was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Reference Wu, Ho and Huang2 It is mainly transmitted by human-to-human contact (droplets and airborne). Preventing transmission and slowing the rate of new infections are the primary goals. The governments worldwide have adopted different strategies and measures to interrupt the transmission of COVID-19, such as containment measures. This term refers to efforts that aim to decrease or interrupt the transmission of COVID-19 in a population by minimizing physical contact between potentially infected individuals and healthy individuals. The basic reproductive number (R0) is used to measure the transmission potential of an epidemic.Reference Heesterbeek and Dietz3 It represents the number of infections caused by an index case within a population with no pre-existing immunity. The value of R0 depends on the contact rate, transmission probability, and duration of infectiousness.Reference Dietz4 R0 = 1 is considered a threshold for the development of an outbreak, referred to as the epidemic threshold.Reference Heffernan, Smith and Wahl5 The time effective reproductive number R(t) represents the population-level transmission potential at time t.Reference Wallinga and Lipsitch6,Reference Cori, Ferguson and Fraser7 It allows tracking the evolution of transmission potential during an outbreak and when immunity intervention measures are implemented. It is also useful to study the impact of the adopted measures on the transmissibility of COVID-19 over time. The values of R(t) can also reveal the time when an outbreak was contained.

The North Africa countries announced different measures. In this study, we evaluate the effectiveness and impact of the adopted measures to contain the spread of COVID-19. We evaluate also the COVID-19 mortality rate on these countries by using the case fatality rate (CFR). We have excluded Libya from this study because there are very few confirmed cases and deaths reported. These figures may not reflect the actual COVID-19 data because of the conflict and the unstable political situation in Libya due to the civil war. In addition, the number of tests performed is very low and the contact tracing is also limited.

METHODS

The data of the daily confirmed cases and number of deaths of COVID-19 were mainly obtained from the European Centre for Disease Prevention.8 For this study, we used the data from the first confirmed cases up to May 13, 2020.

Estimation of Effective Reproductive Number

The R0 is fundamental to quantify the transmission potential of an epidemic in public health practice. However, R0 cannot reflect the time-varying nature of an epidemic. An R(t) can provide more information, because it tracks the subsequent evolution of transmission. For this, we use the Time-dependent (TD) method. It provides a good fit for the epidemic curve and calculates real-time effective reproduction number by averaging the overall transmission networks,Reference Wallinga and Teunis9 and it uses a Bayesian statistical framework. In this method, the generation time (GT) is required and is defined as the interval between a case becoming infected and its subsequent infection of another case. We assume the GT is equal to the incubation period, and we suppose that TD is 5 d and the SD is equal to 1.9.Reference Ferretti, Wymant and Kendall10

The estimation of R(t) was performed by using the statistical package R0, which is coded in R language. In this package, we particularly used a function named ‘est.R0.TD’ to estimate R(t) according to Wallinga and Teunis, and the confidence interval is computed by multinomial simulations at each time step with the expected value of R(t).Reference Wallinga and Teunis9 If R(t) > 1, the number of cases will increase, such as at the start of an epidemic; where R(t) < 1, there will be a decline in the number of cases.

Estimation of CFR

The CRF is interpreted as the conditional probability of death. The naïve CFR (nCFR) is the first estimation, and it is defined as the ratio of the number of cumulative deaths D(t) to the number of cumulative confirmed cases C(t) at time tReference Kucharski and Edmunds11:

$$nCFR(t) = D(t)\,{\hbox /} \,C(t)$$

To obtain a more accurate estimation of CFR, we take into account the time interval [T] between case confirmation to death. The second estimation is the adjusted CFR (aCFR) and is defined as the ratio of the number of cumulative deaths D(t) at time t to the number of cumulative confirmed cases C(t-T) at time t-TReference Nishiura, Klinkenberg and Roberts12:

$$aCFR(t) = D(t)\,{\hbox /}\,C(t - T);$$

The mean time from illness onset to death was estimated at 20.2 d.Reference Linton, Kobayashi and Yang13 For example, aCFR at t = 30 April is equal to the ratio of the number of cumulative deaths at t = 30 April to the number of cumulative confirmed cases at time t-T ≈ t-20, which is April 10.

RESULTS

The R(t) was computed for the studied countries from the date of the first confirmed cases until 13 May (Figure 1). On each graph, the shaded area corresponds to the 95% confidence interval, the black curve to the median, and the black vertical line to the first day of confinement (T1). At the beginning of the epidemic, we observe some peaks of R(t) that correspond to transmission clusters initiated by imported cases and have been controlled. These peaks can be ignored because they are limited to a few days. In the case of weekly incidences instead of daily ones, the curves would be much smoother. R(t) is null on some dates when zero cases were reported.

FIGURE 1 Real-Time Reproductive Number R(t) Values in the COVID-19 Outbreak in the Selected Countries (Morocco, Algeria, Tunisia, and Egypt), Calculated With TD Method. The black vertical line corresponds to the first day of confinement (T1).

In the early phases, R(t) is higher than 3 for all countries. On T1, the value of R(t) was 2.76, 2.78, and 2.09 for Morocco, Tunisia, and Algeria, respectively. To show the effect of the introduced measures by each country, we compare the R(t) value 15 d after the confinement date (T2). R(t) value was 1.045 for Morocco, 0.684 for Tunisia, and 1.233 for Algeria. The R(t) values decreased in particular those of Tunisia, showing the effect of the introduced measures.

On May 13, the R(t) values of Tunisia and Morocco are significantly smaller compared with those of Egypt and Algeria. R(t) value was 0 for Tunisia, 0.545 for Morocco, 1.067 for Algeria, and 0.93 for Egypt. These data indicate that the outbreak is under control in Tunisia and Morocco.

Until May 13, 2020, there were 45 deaths in Tunisia, 188 in Morocco, 522 in Algeria, and 565 in Egypt. The nCFR and aCFR values were estimated until 13 May (Figure 2). At the early stage, aCFR took considerably higher values than nCFR, and this is owing to the time interval T between case confirmation to death. For the 4 countries, the difference between aCFR and nCFR is decreasing during outbreak. For Tunisia, this difference is relatively constant in the last week, which is due to the stabilization of the number of cumulative deaths and the number of cumulative confirmed cases. The nCFR was 2.88% and aCFR was 5.26% for Morocco, nCFR was 4.31% and aCFR was 5.09% for Tunisia, nCFR was 8.21 % and aCFR was 16.91% for Algeria, and nCFR was 5.33% and aCFR was 15.19% for Egypt. The aCFR of Egypt and Algeria was high because of the high number of cumulative deaths.

FIGURE 2 Case Fatality Rate (CFR) in the Selected Countries (Morocco, Algeria, Tunisia, and Egypt), Calculated With naïve CFR (nCFR) and adjusted CFR (aCFR) With T ≈ 20 d.

DISCUSSION

The first confirmed cases were reported on March 2, February 25, March 2, and February 14 in Morocco, Algeria, Tunisia, and Egypt, respectively. Confinement at home was imposed in Morocco and Tunisia on March 20 and in Algeria on March 28. Morocco, Algeria, and Tunisia were applied relatively the same measures but on different dates. In Egypt, the introduced measures were less stringent and confinement was not applied (Table 1).

TABLE 1 Adopted Containment Measures in Selected Countries (Morocco, Algeria, Tunisia, and Egypt)

At the beginning of the epidemic, the reproduction number R(t) of the 4 studied countries has high values, indicating that the outbreak of COVID-19 is in the propagation phase. Morocco and Tunisia applied the first measures of containment from March 13 (11 d after T0), and they imposed confinement at home in the early phases of the epidemic. For these reasons, on T1, the R(t) values were higher than those of Algeria. The effect of the measures and confinement takes time to manifest itself in the data, which is partly logical. A few days are needed for the symptoms to manifest, which creates a time lag.

On T2, the R(t) value of Tunisia and Morocco was lower than that of Algeria. This shows the impact of early confinement. Algeria started by applying restrictive measures and confinement of the Blida region only. It delayed imposing the confinement in the whole country (32 d after T0).

On May 13, R(t) value indicates that the COVID-19 decreased in Morocco and probably it is the beginning of the end of the epidemic in Tunisia. For Algeria and Egypt, R(t) values remained around 1, which indicate that the number of new cases was stable. An important thing to keep in mind when interpreting the results of R(t) is that this number depends heavily on the counts of laboratory-confirmed cases reported, which may not reflect the actual epidemic. Therefore, even if Egypt and Algeria have R(t) = 0.93 and R(t) = 1.067, respectively, their cumulative cases numbers are very low compared with those of the neighboring European countries, such as France, Spain, and Italy.8

The mortality rate is relatively high in Algeria and Egypt and low in Tunisia and Morocco (Figure 2). COVID-19 patients combined with high age, diabetes, obesity, or cardiovascular diseases were reported to have a higher risk of mortality. The prevalence of these risk factors is similar in the studied countries (Table 2).14-Reference Roth, Johnson and Abajobir17 Therefore, the mortality rate difference can be attributed to the containment measures, which were applied early in Tunisia and Morocco. In Algeria and Egypt, continued monitoring of deaths caused by COVID-19 is required to better care for patients.

TABLE 2 Median Age, Diabetes, Obesity, and Cardiovascular Diseases (CVD) Prevalence in the Selected Countries (Morocco, Algeria, Tunisia, and Egypt)

CONCLUSIONS

To control the spread of COVID-19, the studied countries have chosen to adopt measures to avoid increased morbidity and, thereby, decrease the pressure on the health system. The early application of containment measures and confinement could help contain the spread of the epidemic and keep the number of deaths low. These measures might be useful for other countries that are experiencing the start of local COVID-19 outbreaks. They could also serve to inform evidence-based decisions by governments for future epidemics or pandemics to prevent the spread of new pathogens.

Conflict of Interest Statement

The authors have no conflicts of interest to declare.

References

REFERENCES

Zhu, N, Zhang, D, Wang, W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727733.CrossRefGoogle ScholarPubMed
Wu, Y, Ho, W, Huang, Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020; 395(10228):949950 CrossRefGoogle ScholarPubMed
Heesterbeek, JAP, Dietz, K. The concept of R0 in epidemic theory. Stat Neerl. 1996;50(1):89110.CrossRefGoogle Scholar
Dietz, K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res. 1993;2:2341.CrossRefGoogle ScholarPubMed
Heffernan, JM, Smith, RJ, Wahl, LM. Perspectives on the basic reproductive ratio. J R Soc Interface. 2005;2:281293.CrossRefGoogle ScholarPubMed
Wallinga, J, Lipsitch, M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2006;274:599604.Google Scholar
Cori, A, Ferguson, NM, Fraser, C, et al. A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol. 2013;178:15051512.CrossRefGoogle ScholarPubMed
European Centre for Disease Prevention and Control https://www.ecdc.europa.eu/en/publications-data. Accessed May 14, 2020.Google Scholar
Wallinga, J, Teunis, P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol. 2004;160(6):509516.CrossRefGoogle ScholarPubMed
Ferretti, L, Wymant, C, Kendall, M, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020;368(6491):eabb6936.CrossRefGoogle ScholarPubMed
Kucharski, AJ, Edmunds, WJ. Case fatality rate for Ebola virus disease in west Africa. Lancet. 2014;384(9950):1260.CrossRefGoogle ScholarPubMed
Nishiura, H, Klinkenberg, D, Roberts, M, et al. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS One. 2009;4(8):e6852.CrossRefGoogle ScholarPubMed
Linton, NM, Kobayashi, T, Yang, Y, et al. Epidemiological characteristics of novel coronavirus infection: a statistical analysis of publicly available case data. medRxiv. doi: 10.1101/2020.01.26.20018754.Google Scholar
Index Mundi website. Diabetes prevalence. https://www.indexmundi.com/facts/indicators/SH.STA.DIAB.ZS/rankings. Accessed May 14, 2020.Google Scholar
Britannica ProCon.org. Global obesity levels. https://obesity.procon.org/global-obesity-levels/. Accessed May 14, 2020.Google Scholar
Roth, GA, Johnson, C, Abajobir, A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):125.CrossRefGoogle ScholarPubMed
Figure 0

FIGURE 1 Real-Time Reproductive Number R(t) Values in the COVID-19 Outbreak in the Selected Countries (Morocco, Algeria, Tunisia, and Egypt), Calculated With TD Method. The black vertical line corresponds to the first day of confinement (T1).

Figure 1

FIGURE 2 Case Fatality Rate (CFR) in the Selected Countries (Morocco, Algeria, Tunisia, and Egypt), Calculated With naïve CFR (nCFR) and adjusted CFR (aCFR) With T ≈ 20 d.

Figure 2

TABLE 1 Adopted Containment Measures in Selected Countries (Morocco, Algeria, Tunisia, and Egypt)

Figure 3

TABLE 2 Median Age, Diabetes, Obesity, and Cardiovascular Diseases (CVD) Prevalence in the Selected Countries (Morocco, Algeria, Tunisia, and Egypt)